Funded startup

Who invested in Apex Molecular

One round we have observed, with the one investor named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 26 Oct 2026

$318Kraised across 1 round since 2018, from 1 source

Latest round
Debt, $318KOct 2018
Investors
1
See who backed them

The rounds

  1. Oct 2018
    Debt$318K

    Source recorded

Founders and team

From Apex Molecular's own website: 5 on the team.

  • Dr Stuart BrownChief Executive Officer ▾
  • Dr Thomas ScreenChief Operating Officer ▾
  • Dr Peter JacksonNon–Executive Director ▾
  • Dr Tony FlinnNon-Executive Chairman ▾
  • Mark WarburtonNon–Executive Director ▾

Everyone who backed them

Missing a round, or an investor who was in one? Tell us.

Quick answers about Apex Molecular

Who invested in Apex Molecular?

Apex Molecular's investors include Northern Powerhouse Investment Fund.

How much has Apex Molecular raised?

Apex Molecular has raised $318K across 1 round since 2018.

When did Apex Molecular last raise?

Apex Molecular's most recent round was a Debt of $318K in Oct 2018.

What was Apex Molecular's biggest round?

Its most recent round, $318K in Oct 2018, is also its largest on record.

Who backed Apex Molecular first?

Apex Molecular's first round on record, in Oct 2018, was backed by Northern Powerhouse Investment Fund.

What stage is Apex Molecular at?

Apex Molecular's latest named round is a Debt, in Oct 2018.

Companies like Apex Molecular

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.